CClinicalTrials.gg
CompletedNCT00105664C3PUpdated Apr 7, 2015

Collaborative Cardiac Care Project

An interventional study of Collaborative care model and Group interventions in Myocardial Ischemia, Angina Pectoris and Coronary Disease, sponsored by US Department of Veterans Affairs. Completed at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-04-07.

Sponsored by US Department of Veterans Affairs · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
287
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Data from VA-funded studies and the broader literature indicate that chronic stable angina (CSA) is prevalent, under recognized, under treated and associated with reduced quality of life. There are substantial opportunities for improving care of patients with this debilitating and potentially fatal problem. Because primary care providers manage most patients with CSA, efforts to improve care must necessarily involve the primary care delivery system. C3P is composed of a set of interventions employing a Collaborative Care Team model, which has been shown to be effective in managing other chronic illnesses in the primary care setting.

Read the detailed description

Objectives of the proposed project are to: 1) ascertain whether a collaborative approach to managing CSA in primary care results in better symptom control and quality of life than routine care; 2) assess whether the practice of providers assigned to the intervention group is more consistent with national clinical practice guidelines than that of control providers; 3) assess satisfaction of both patients and providers with this approach to management; and 4) assess marginal cost-effectiveness.

02

Conditions studied

  • Myocardial Ischemia
  • Angina Pectoris
  • Coronary Disease

Keywords

  • Outcomes Assessment
  • Primary Health Care
  • Group Process
03

In context

Coronary Disease

2,839 studies on the registry are indexed under Coronary Disease; 311 are open to participants now.

This study's enrollment of 287 is above the median of 124 across 1,583 interventional studies indexed under Coronary Disease.

Browse Coronary Disease studies →

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 658 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Providers:

  • Staff (MD, PA, NP) or resident (R1, R2)
  • at least 1 participating patient

Patients

  • assigned to participating provider
  • diagnosis consistent with IHD
  • 2 visits in past year
  • frequent angina symptoms (SAQ freq. score less than 70)

Exclusion criteria

Exclusion Criteria:

Providers:

  • No participating patients

Patients:

  • cognitive impairment (inability to complete questionnaires and phone interviews)
  • non-participating provider
  • life expectancy of less than 24 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
287 participants (actual)

Study arms

  • Other
    Arm 1

    Procedure: Collaborative care model · Procedure: Group interventions · Procedure: Facilitated consultation

Interventions

  • ProcedureCollaborative care model
  • ProcedureGroup interventions
  • ProcedureFacilitated consultation
06

What researchers measure

Primary outcomes

  1. Symptom control, quality of life and satisfaction at one year; improved practitioner compliance with national clinical practice guidelines over the one-year intervention period

Secondary outcomes

  1. Marginal cost effectiveness during one-year study period

07

Study locations

4 sites
  • VA Palo Alto Health Care System, Palo Alto, CA
    Palo Alto, California 94304-1290, United States
  • VA Eastern Colorado Health Care System, Denver, CO
    Denver, Colorado 80220, United States
  • VA Portland Health Care System, Portland, OR
    Portland, Oregon 97239, United States
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA
    Seattle, Washington 98108, United States
08

References and documents

Publications

  • Wang L, Porter B, Maynard C, Bryson C, Sun H, Lowy E, McDonell M, Frisbee K, Nielson C, Fihn SD. Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration. Am J Cardiol. 2012 Nov 1;110(9):1342-9. doi: 10.1016/j.amjcard.2012.06.038. Epub 2012 Jul 21. PubMed 22819429 ↗
  • Fihn SD, Bucher JB, McDonell M, Diehr P, Rumsfeld JS, Doak M, Dougherty C, Gerrity M, Heidenreich P, Larsen G, Lee PI, Lucas L, McBryde C, Nelson K, Plomondon ME, Stadius M, Bryson C. Collaborative care intervention for stable ischemic heart disease. Arch Intern Med. 2011 Sep 12;171(16):1471-9. doi: 10.1001/archinternmed.2011.372. PubMed 21911632 ↗
  • Fan VS, Bridevaux PO, McDonell MB, Fihn SD, Besser LM, Au DH. Regional variation in health status among chronic obstructive pulmonary disease patients. Respiration. 2011;81(1):9-17. doi: 10.1159/000320115. Epub 2010 Aug 17. PubMed 20720400 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00105664
Lead sponsor
US Department of Veterans Affairs
Responsible party
Sponsor
First posted
Mar 17, 2005
Start date
Oct 2004
Completion
Jul 2007
Last update
Apr 7, 2015

Study contacts

Stephan D. Fihn, MD MPH
principal investigator · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion